We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.83B
AUM Growth
+$439M
Cap. Flow
-$277M
Cap. Flow %
-4.05%
Top 10 Hldgs %
26.62%
Holding
140
New
27
Increased
39
Reduced
39
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$127M
2
ANAB icon
AnaptysBio
ANAB
+$76M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$62.1M
4
TSM icon
TSMC
TSM
+$59.5M
5
LKQ icon
LKQ Corp
LKQ
+$45.9M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$89.2M
2
CNC icon
Centene
CNC
+$80.2M
3
HOLX
Hologic
HOLX
+$75.2M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$65.8M
5
BAX icon
Baxter International
BAX
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 49.61%
2 Technology 13.09%
3 Communication Services 5.22%
4 Consumer Discretionary 2.37%
5 Financials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONCE
51
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$46.9M 0.69%
859,480
-17,299
-2% -$1.18M
ICLR icon
52
Icon
ICLR
$12.6B
$46M 0.67%
299,037
-133,275
-31% -$19.1M
PYPL icon
53
PayPal
PYPL
$48.9B
$45.6M 0.67%
518,904
+7,150
+1% +$630K
LKQ icon
54
LKQ Corp
LKQ
$5.72B
$43.7M 0.64%
+1,380,466
New +$45.9M
DXCM icon
55
DexCom
DXCM
$32.2B
$43.7M 0.64%
+1,221,216
New +$37.9M
CRUS icon
56
Cirrus Logic
CRUS
$6.53B
$43.4M 0.64%
1,125,349
+368,803
+49% +$15.3M
MA icon
57
Mastercard
MA
$506B
$41.5M 0.61%
186,526
+28,762
+18% +$6M
GWRE icon
58
Guidewire Software
GWRE
$12.6B
$41.3M 0.6%
408,373
+104,117
+34% +$10M
CSII
59
DELISTED
Cardiovascular Systems, Inc.
CSII
$39.8M 0.58%
1,017,917
-213,004
-17% -$7.87M
MSFT icon
60
Microsoft
MSFT
$3.45T
$39.8M 0.58%
348,110
+338,972
+3,709% +$36.7M
WCG
61
DELISTED
Wellcare Health Plans, Inc.
WCG
$38.9M 0.57%
+121,313
New +$34.4M
COUP
62
DELISTED
Coupa Software Incorporated
COUP
$38M 0.56%
479,934
-55,958
-10% -$3.89M
SLDB icon
63
Solid Biosciences
SLDB
$794M
$37.7M 0.55%
53,318
+22,027
+70% +$13.8M
GSKY
64
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$36.7M 0.54%
2,038,160
+1,225,832
+151% +$23.4M
INGN icon
65
Inogen
INGN
$175M
$35.1M 0.51%
+143,625
New +$33.2M
ACOR
66
CALL
DELISTED
Acorda Therapeutics
ACOR
$33.4M 0.49%
+14,159
New +$43.8M
ATVI
67
DELISTED
Activision Blizzard
ATVI
$32.5M 0.48%
390,334
-162,325
-29% -$12.3M
BABA icon
68
Alibaba
BABA
$293B
$32.3M 0.47%
196,280
-201,506
-51% -$35.7M
NVDA icon
69
NVIDIA
NVDA
$4.86T
$32M 0.47%
4,550,120
-636,040
-12% -$4.14M
ALDR
70
DELISTED
Alder Biopharmaceuticals
ALDR
$31.9M 0.47%
1,916,664
-289,249
-13% -$5.23M
RAMP icon
71
LiveRamp
RAMP
$2.3B
$30.4M 0.45%
+615,767
New +$27.3M
NFLX icon
72
Netflix
NFLX
$299B
$29M 0.42%
774,520
-220
-0% -$7.99K
ELAN icon
73
Elanco Animal Health
ELAN
$13.2B
$28.3M 0.41%
+811,700
New +$28.5M
ALLK
74
DELISTED
Allakos
ALLK
$25.2M 0.37%
+624,735
New +$25.6M
ACOR
75
DELISTED
Acorda Therapeutics
ACOR
$24.5M 0.36%
10,395
-7,611
-42% -$23.6M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q3 2018 Portfolio in Review

As of Q3 2018, PFM Health Sciences held 140 positions worth $6.83B, up 6.9% from $6.39B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PFM Health Sciences withdrew a net $277M in Q3 2018, closing 23 positions and reducing 39 holdings. Its most notable exit was Baidu, an estimated $89.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Allergan plc worth $131M.

  • PFM Health Sciences's largest Q3 2018 buy was Allergan plc: 689,949 shares worth $131M.
  • PFM Health Sciences added most to AnaptysBio in Q3 2018, an estimated $76M increase.
  • PFM Health Sciences's biggest Q3 2018 reduction was Endocyte, Inc. Common Stock, cutting an estimated $65.8M.
  • PFM Health Sciences fully exited Baidu in Q3 2018, selling an estimated $89.2M.
  • PFM Health Sciences's ten largest holdings make up 27% of its $6.83B portfolio in Q3 2018.
  • PFM Health Sciences opened 27 new positions and closed 23 in Q3 2018.
  • PFM Health Sciences's portfolio value rose 6.9% quarter-over-quarter to $6.83B.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.